OPTOMED — Optomed Oyj Share News
0.000.00%
Last trade - 00:00- €30.19m
- €25.86m
- €17.10m
Brief: Optomed Q2 EBITDA EUR -1.185 Million
Brief: Optomed Raises EUR 7.9 Mln In Directed Share Issue
Brief: Optomed To Establish JV In China With Zhongbao
Brief: Optomed Oyj Says No Dividend Will Be Paid For Year 2023.
Brief: Optomed Keeps Outlook Unchanged
Brief: Optomed Q1 EBITDA EUR -648 Thousand
Brief: Optomed Wins Extension Contract Following Public Tender
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
Brief: Optomed Aurora With AEYE Has Received FDA Clearance In US
Brief: Optomed Says It Has No Updates On FDA Clearance Process
Brief: Optomed Q4 EBITDA EUR -757 Thousand
Brief: Optomed's Outlook Unchanged
Brief: Optomed Q3 EBITDA EUR -48 Thousand
Brief: Optomed Completes Directed Share Issue Raising EUR 4.3 Mln
Brief: Optomed To Supply Large Diabetic Retinopathy Screening Solution To Spain
Brief: Optomed Outlook Remains Unchanged, Expects FY 2023 Revenue To Grow
Brief: Optomed Q2 EBITDA EUR -462 Thousand
Brief: Optomed Oyj Board Of Directors Has Appointed Juho Himberg As New CEO Of Optomed PLC
Brief: Optomed CEO Seppo Kopsala To Leave His Position